本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一、董事会会议召开情况 山东赫达集团股份有限公司（以下简称"公司"）已于2025年12月24日以电话及书面方式向公司全体董事 发出了关于召开第九届董事会第二十九次会议的通知（以下简称"本次会议"或"会议"）。本次会议于 2025年12月26日在公司会议室召开，应出席董事9人，实际出席董事9人，本次会议由董事长毕于东先生 召集，因其出差，经半数以上董事同意，本次会议由董事毕松羚先生主持，以现场结合通讯会议方式召 开。本次会议召集和召开程序符合《中华人民共和国公司法》《深圳证券交易所股票上市规则》和《公 司章程》的有关规定。 二、董事会会议审议情况 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002810证券简称：山东赫达 公告编号：2025-103 债券代码：127088 债券简称：赫达转债 山东赫达集团股份有限公司 关于第九届董事会第二十九次会议 决议的公告 经全体与会董事认真审议，作出决议如下： 审议通过《关于对外投资购买股权进展暨签署〈股权转让协议之补充协议〉的议案》。 表决结果：9票赞成，0 ...

Core Viewpoint - The company faces significant anti-dumping and countervailing duties from the U.S. Department of Commerce, impacting its exports of hard-shell capsules to the U.S. market, prompting the establishment of a special task force to address the situation [1][3]. Group 1: Anti-Dumping and Countervailing Duties - The preliminary anti-dumping duty rate for the company's subsidiary, Shandong Hershey Capsule Co., Ltd., is set at 172.24%, while other Chinese producers/exporters face rates between 5.4% and 88.82% [1]. - The preliminary countervailing duty rate for Shandong Hershey is 6.82%, with other Chinese producers/exporters facing rates between 3.45% and 8.53% [1]. - The U.S. will require importers to pay these duties as a cash deposit until the final rates are determined after the first annual review, expected to be published in October 2025 [1]. Group 2: Company Response and Strategy - The company is actively preparing for a field investigation by the U.S. Department of Commerce to seek a fair final ruling and has engaged a legal team to challenge the preliminary ruling [3]. - The company has maintained a stock of products in the U.S. that can meet market demand for 5 to 6 months, indicating proactive inventory management [3]. - The company is advancing a project to establish a plant in the U.S. with a capacity of 20 billion capsules per year, which has completed site selection and initial negotiations [3]. Group 3: Business Performance and Future Outlook - In 2024, the company reported revenue of 1.957 billion yuan, a year-on-year increase of 25.72%, with net profit reaching 222 million yuan, up 0.65% [4]. - Overseas revenue for 2024 was 1.232 billion yuan, a 36.19% increase, accounting for 62.96% of total revenue, reflecting deepened international market expansion [4]. - The company plans to achieve revenue of 2.25 billion yuan in 2025, with specific targets for various segments, including 1.69 billion yuan from cellulose ether and 400 million yuan from plant capsules [4].